These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21088139)

  • 21. [Research advances on circumventing tumor multidrug resistance].
    Miao ZH; Ding J
    Ai Zheng; 2003 Aug; 22(8):886-92. PubMed ID: 12917042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India.
    Atre SR; Murray MB
    J Public Health Policy; 2016 Aug; 37(3):277-299. PubMed ID: 27153155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of bacteria isolated from neonatal foal samples submitted to a New Zealand veterinary pathology laboratory (2004 to 2013).
    Toombs-Ruane LJ; Riley CB; Kendall AT; Hill KE; Benschop J; Rosanowski SM
    N Z Vet J; 2016 Mar; 64(2):107-11. PubMed ID: 26496417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "A horse! a horse! my kingdom for a horse!" Versions of Greek horse medicine in medieval Italy.
    Fischer KD
    Medizinhist J; 1999; 34(2):123-38. PubMed ID: 10444945
    [No Abstract]   [Full Text] [Related]  

  • 25. Autophagy and multidrug resistance in cancer.
    Li YJ; Lei YH; Yao N; Wang CR; Hu N; Ye WC; Zhang DM; Chen ZS
    Chin J Cancer; 2017 Jun; 36(1):52. PubMed ID: 28646911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrosequencing analysis for mutations in embB codon306 among clinical mycobacterium tuberculosis isolates from Qingdao, China.
    Zhang H; Chen X; Wang Z; Ren Z; Wu J; Sun H; Bai X
    Int J Clin Exp Med; 2015; 8(7):11276-82. PubMed ID: 26379935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in multidrug-resistant tuberculosis in Tehran, Iran: an analysis of published data.
    Nasiri MJ; Heidary M; Goudarzi H; Tabarsi P
    GMS Hyg Infect Control; 2019; 14():Doc11. PubMed ID: 31538044
    [No Abstract]   [Full Text] [Related]  

  • 28. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
    Wu Q; Yang Z; Nie Y; Shi Y; Fan D
    Cancer Lett; 2014 Jun; 347(2):159-66. PubMed ID: 24657660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atypical MDR].
    Yokomizo A; Taniguchi K; Hasegawa S; Abe T; Kubo T; Makino Y; Wada M; Kohno K; Kuwano M
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1123-9. PubMed ID: 7913311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detecting gene-gene/environment interactions by model-based multifactor dimensionality reduction].
    Fan W; Shen C; Guo Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Nov; 36(11):1305-10. PubMed ID: 26850256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer].
    Yang XK; Xing H; Gao QL; Wang W; Wu SF; Lu YP; Wang SX; Ma D
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):425-8. PubMed ID: 14575561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiresistant tuberculosis in the Czech Republic in 1998 and causes of its occurrence].
    Krejbich F; Trnka L; Danková D
    Cas Lek Cesk; 2001 Jun; 140(13):409-10. PubMed ID: 11507953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells.
    Feng W; Zhang M; Wu ZX; Wang JQ; Dong XD; Yang Y; Teng QX; Chen XY; Cui Q; Yang DH
    Front Oncol; 2020; 10():955. PubMed ID: 32670878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDR-1 gene C/T polymorphism in COPD: data from Aegean part of Turkey.
    Toru U; Ayada C; Genç O; Turgut S; Turgut G; Bulut I
    Int J Clin Exp Med; 2014; 7(10):3573-7. PubMed ID: 25419400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phytochemicals: Potential Lead Molecules for MDR Reversal.
    Tinoush B; Shirdel I; Wink M
    Front Pharmacol; 2020; 11():832. PubMed ID: 32636741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The relationship between in vitro chemosensitivity of human breast cancer to MDR related drugs and expression of mdr-1 gene].
    Xu J; Song S; Liu X
    Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):371-3. PubMed ID: 9772495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis (MDR- TB) Compared with Non-MDR-TB Infections in Peninsular Malaysia.
    Elmi OS; Hasan H; Abdullah S; Mat Jeab MZ; Ba Z; Naing NN
    Malays J Med Sci; 2016 Jul; 23(4):17-25. PubMed ID: 27660541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care.
    Biadglegne F; Sack U; Rodloff AC
    Antimicrob Resist Infect Control; 2014; 3(1):31. PubMed ID: 25685333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors.
    Rumpold H; Salvador C; Wolf AM; Tilg H; Gastl G; Wolf D
    Biochem Biophys Res Commun; 2007 Sep; 361(2):549-54. PubMed ID: 17662692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multidrug resistance: diagnostic approaches and difficulties].
    Rideg O; Csutora P; Magyarlaki T; Teibert A; Nagy T; Kovács LG; Miseta A
    Orv Hetil; 2005 May; 146(20):995-1001. PubMed ID: 15945242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.